Evoke Wealth, LLC Summit Therapeutics Inc. Transaction History

Evoke Wealth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	BUY	$1.38 - $5.41 $34,800 - $136,429	25,218 New	25,218 $44,000
Q3 2022 Nov 07, 2022	BUY	$0.89 - $1.63 $2,670 - $4,890	3,000 Added 60.0%	8,000 $10,000
Q2 2022 Aug 04, 2022	BUY	$0.92 - $2.38 $4,600 - $11,900	5,000 New	5,000 $5,000
Q4 2021 Feb 09, 2022	SELL	$2.45 - $5.64 $7,840 - $18,048	-3,200 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$5.15 - $8.46 $16,480 - $27,072	3,200 New	3,200 $24,000

139

64.4M

1.06M

1.02M

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $3.74B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Evoke Wealth, LLC with notifications on news.